Gut-Brain Axis
Microbiome-Nervous System Communication
Evidence grade 3 of 5, Mixed. Read how the Atlas grades evidence.
23 human trials, about 500 studies, Mostly preclinical + emerging. The written rationale for this grade is still being prepared.
- FDA
- Not applicable
- WADA
- Not prohibited
Reference only. Not medical advice.
What can go wrong
This entry touches mental health, which is a sensitive area. The gut-brain axis is not a treatment for depression, anxiety, or any psychiatric condition, and probiotics should not be positioned as one. Much of the foundational evidence is in germ-free and gnotobiotic mice; human 'psychobiotic' results are preliminary, heterogeneous, and sometimes fail to replicate (for example, the flagship JB-1 strain showed no effect in healthy men). Marketing claims frequently run ahead of the human data. Anyone experiencing depression, anxiety, or other mental-health symptoms should consult a qualified healthcare or mental-health provider and should not stop, delay, or replace prescribed treatment in favor of a supplement. Effects may differ in pregnancy, in children, and in people who are immunocompromised, where a clinician's guidance matters most.
The gut-brain axis is the bidirectional communication network linking the microbiome and the central nervous system through the vagus nerve (about 80% of whose fibers are afferent, carrying signals from gut to brain), microbial metabolites such as short-chain fatty acids, immune signaling, neurotransmitter chemistry (enterochromaffin cells in the gut make an estimated 90 to 95% of the body serotonin, and gut bacteria help regulate that synthesis), and modulation of the HPA stress axis. The mechanism is strongly supported in animals: germ-free mice show an exaggerated stress response that specific bacteria can normalize. Human 'psychobiotic' work, probiotics studied for mood and stress, is the frontier and is where the evidence thins: results are preliminary, heterogeneous, and inconsistent, with at least one flagship strain failing to translate from mice to healthy people. The established biology and the human mental-health claims should be read as two separate things.
The microbiome talks to the brain. 90% of serotonin is made in the gut.
What it is invoked to explain
Claims this idea is used to support. Whether it supports them is the rest of the entry.
What people get wrong
Often saidProbiotics are proven to treat depression and anxiety
ActuallyThe gut-brain biology is real and, in animals, robust, but human 'psychobiotic' trials are early, heterogeneous, and inconsistent. A 2024 meta-analysis of 23 RCTs in clinically diagnosed patients did find reduced depression scores, yet rated the certainty of that evidence LOW because of high heterogeneity (I-squared 85%), risk of bias, and possible publication bias. The mechanism is far better established than any specific clinical mental-health claim, and probiotics are not a treatment for depression or anxiety.
Often said'90% of your serotonin is made in the gut' means probiotics fix brain serotonin and mood
ActuallyEnterochromaffin cells in the gut do produce an estimated 90 to 95% of the body serotonin, and gut bacteria help regulate that synthesis (Yano 2015, Cell). But peripheral gut serotonin does not cross the blood-brain barrier, so it is not the same pool as brain serotonin. The figure is associated with gut motility and platelet function far more directly than with mood, and it does not license a claim that a probiotic raises brain serotonin.
Often saidWhat works in mice works in people
ActuallyThe single clearest cautionary tale in the field is L. rhamnosus JB-1: vagus-dependent anti-anxiety effects in mice (Bravo 2011, PNAS) did NOT reproduce in healthy men, who showed no change in stress, mood, or cognition (Kelly 2017, 'Lost in translation'). Germ-free-mouse and humanized-rodent findings frequently overstate causality relative to what transfers to humans.
Often saidThe gut-brain axis is a fringe or alternative-medicine idea
ActuallyIt is mainstream neuroscience and physiology. The vagus nerve is roughly 80% afferent, carrying gut information to the brainstem and onward to the amygdala, hippocampus and prefrontal cortex (Bonaz 2018, Front Neurosci). The dispute is not whether the axis exists, it is how much of the animal mechanism translates into reliable human mental-health benefit.
Who profits, and who pushes back
John R. Kelly and colleagues (APC Microbiome Ireland)
Reporting their own randomized crossover trial, the authors found the flagship psychobiotic L. rhamnosus JB-1 produced no effect over placebo on stress, mood, cognition, or the HPA stress response in 29 healthy men, and framed the result as showing 'the challenges associated with moving promising preclinical studies to healthy human participants.'
Jens Walter and co-authors
The authors argue that causal claims about the gut microbiome derived from humanized-rodent studies are frequently overstated relative to the underlying experimental evidence, and caution that striking effects in colonized mice should not be read as established human causation.
European Food Safety Authority (EFSA)
EFSA has not issued a single positive opinion authorizing a probiotic health claim for mental health, mood, or cognition, citing insufficient strain characterization and poorly substantiated cause-and-effect relationships, a standing regulatory judgment that the human evidence is not yet sufficient.
Dr. John Cryan & Dr. Ted Dinan
Pioneers of gut-brain and psychobiotic research; coined "psychobiotics." Academic, foundational.
Wellness and supplement marketers
Sells this. Has a commercial interest in a product sold as this compound, as of July 2026.
Frequently invoke the gut-brain axis to sell mood probiotics ahead of the human evidence.
Where the research comes from
| Place | Share of published research |
|---|---|
| USA | 32% |
| Europe | 28% |
| Ireland | 22% |
| Other | 18% |
Research published from: Ireland, Global.
How we got here
Serious gut-brain science emerged largely from Japan and Ireland rather than from a single Western origin. In 2004, Nobuyuki Sudo and colleagues at Kyushu University in Japan reported in The Journal of Physiology that germ-free mice mounted an exaggerated HPA stress response that was reversed by colonizing them with Bifidobacterium infantis, one of the first hard demonstrations that gut microbes shape brain stress circuitry. At APC Microbiome Ireland in Cork, John Cryan and Ted Dinan, working with Javier Bravo, John Bienenstock and others, showed in 2011 (PNAS) that a Lactobacillus strain altered GABA receptors and anxiety-like behavior in mice through the vagus nerve, an effect that disappeared after vagotomy. In 2013 Dinan, Stanton and Cryan coined 'psychobiotics' in Biological Psychiatry. In 2015 Elaine Hsiao's group at Caltech showed gut bacteria regulate host serotonin. The recurring challenge across every chapter has been translating vivid rodent biology into reliable human benefit.
- 2004Sudo et al. (Kyushu University, Japan) show germ-free mice have an exaggerated HPA stress response reversed by Bifidobacterium infantis (J Physiol)
- 2011Bravo, Cryan, Dinan, Bienenstock et al. show L. rhamnosus JB-1 alters GABA receptors and anxiety-like behavior in mice via the vagus; effect abolished by vagotomy (PNAS)
- 2013Tillisch et al. report fermented-milk probiotic modulates brain response to emotional faces in 12 healthy women (Gastroenterology); Dinan, Stanton and Cryan coin 'psychobiotics' (Biological Psychiatry)
- 2015Yano et al. (Hsiao lab, Caltech) show indigenous spore-forming gut bacteria regulate host serotonin biosynthesis in enterochromaffin cells (Cell)
- 2016Allen et al. report B. longum 1714 attenuates cortisol and subjective anxiety to a stress test in 22 healthy volunteers (Translational Psychiatry)
- 2017Kelly et al. 'Lost in translation': flagship strain L. rhamnosus JB-1 fails to modulate stress or cognition in 29 healthy men, exposing the mouse-to-human gap (Brain Behav Immun)
- 2018Bonaz, Bazin, Pellissier review confirms the vagus nerve is ~80% afferent, framing it as the interface of the microbiota-gut-brain axis (Front Neurosci)
- 2019-2024Multiple human RCTs and meta-analyses accumulate; a 2024 pooled analysis of 23 RCTs finds signals for depression and anxiety but with high heterogeneity and low-to-moderate certainty
At a glance
- Vagus nerve
- 80% afferent (gut to brain)
- Gut serotonin
- ~90-95% of body total
- Psychobiotics
- B. longum 1714, L. rhamnosus JB-1
- Pioneers
- Cryan & Dinan (Cork)
What this entry does not yet cover
What follows is unfinished work on our side, not a finding about Gut-Brain Axis. A short entry is not a safe entry.
- Cost and market. We have not documented what it sells for or who sells it.
- Supply chain. We have not mapped where it is made.
- Who uses it. We have not documented the user groups.
- What could change. No forward-looking summary yet.
- How it compares. We have not set it against the alternatives.
- Children and teenagers. We have not checked what is known about younger people.
Sources
The vagus nerve is approximately 80% afferent (gut to brain), positioning it as the interface of the microbiota-gut-brain axis
Germ-free mice show an exaggerated HPA/corticosterone stress response, reversed by monocolonization with Bifidobacterium infantis; foundational gut-brain mechanism
L. rhamnosus JB-1 alters GABA-receptor expression and anxiety/depression-like behavior in mice via the vagus nerve; effects abolished by vagotomy
Indigenous spore-forming gut bacteria regulate host serotonin biosynthesis in enterochromaffin cells; ~90% of body serotonin is gut-derived
Definition and coining of 'psychobiotic' as a live organism that produces a mental-health benefit; class of probiotics producing neuroactive substances
Fermented-milk probiotic modulated brain response to an emotional-faces task in 12 healthy women; small sample, not designed to test mechanism
Flagship strain L. rhamnosus JB-1 failed to modulate stress, mood, or cognition in 29 healthy men; key mouse-to-human translation failure
Kelly et al., 'Lost in translation?', Brain, Behavior, and Immunity (2017)
B. longum 1714 attenuated cortisol output and subjective anxiety to a stress test and improved some measures in 22 healthy volunteers; positive human signal
Meta-analysis of 23 RCTs (1,401 clinically diagnosed patients): probiotics reduced depression (SMD -0.96, I-squared 85%, LOW certainty) and anxiety (SMD -0.59, moderate certainty)
Nutrition Reviews, systematic review and meta-analysis (2024/2025)
Causal claims about the gut microbiome derived from humanized-rodent studies are frequently overstated relative to the evidence
Walter et al., 'Establishing or Exaggerating Causality for the Gut Microbiome,' Cell (2019)
No probiotic has an EFSA-authorized health claim for mental health, mood, or cognition; claims rejected for insufficient substantiation
Narrative overview of psychobiotics confirming no EFSA-authorized mental-health probiotic claim and the emerging, unsettled state of the evidence
'A Narrative Review of Psychobiotics: Probiotics That Influence the Gut-Brain Axis', PMC (2024)